These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31406477)

  • 1. Paclitaxel-loaded nanobubble targeted to pro-gastrin-releasing peptide inhibits the growth of small cell lung cancer.
    Wang JP; Yan JP; Xu J; Yin TH; Zheng RQ; Wang W
    Cancer Manag Res; 2019; 11():6637-6649. PubMed ID: 31406477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanobubbles as ultrasound contrast agent for facilitating small cell lung cancer imaging.
    Wang JP; Zhou XL; Yan JP; Zheng RQ; Wang W
    Oncotarget; 2017 Sep; 8(44):78153-78162. PubMed ID: 29100457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated siRNA targeting c-Met inhibits proliferation and invasion of small-cell lung cancer (SCLC) cells.
    Wang ZX; Lu BB; Yang JS; Wang KM; De W
    J Surg Res; 2011 Nov; 171(1):127-35. PubMed ID: 20338593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer.
    Zhou J; Chen J; Mokotoff M; Zhong R; Shultz LD; Ball ED
    Clin Cancer Res; 2003 Oct; 9(13):4953-60. PubMed ID: 14581370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjudin synergizes with paclitaxel and inhibits cell growth and metastasis by regulating the sirtuin 3-Forkhead box O3a axis in human small-cell lung cancer.
    Wang X; Zeng Q; Li Z; Yang X; Xia W; Chen Z
    Thorac Cancer; 2019 Apr; 10(4):642-658. PubMed ID: 30779316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of nanobubbles containing paclitaxel and survivin inhibitor YM155 against lung cancer.
    Başpınar Y; Erel-Akbaba G; Kotmakçı M; Akbaba H
    Int J Pharm; 2019 Jul; 566():149-156. PubMed ID: 31129344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Cellular Uptake and Gene Silencing Activity of Survivin-siRNA via Ultrasound-Mediated Nanobubbles in Lung Cancer Cells.
    Akbaba H; Erel-Akbaba G; Kotmakçı M; Başpınar Y
    Pharm Res; 2020 Aug; 37(8):165. PubMed ID: 32761250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of pro-gastrin releasing peptide promotes the cell proliferation and progression in small cell lung cancer.
    Gong Z; Lu R; Xie S; Jiang M; Liu K; Xiao R; Shen J; Wang Y; Guo L
    Biochem Biophys Res Commun; 2016 Oct; 479(2):312-318. PubMed ID: 27639644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [MiR-665 Promotes the Biological Behavior of Small Cell Lung Cancer by Targeting LLGL1].
    Liu R; Zhang L; Xu Z; Cui Y
    Zhongguo Fei Ai Za Zhi; 2020 Apr; 23(4):223-232. PubMed ID: 32222154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Taxanes to Castration-Resistant Prostate Cancer Cells by Nanobubbles and Extracorporeal Shock Waves.
    Marano F; Rinella L; Argenziano M; Cavalli R; Sassi F; D'Amelio P; Battaglia A; Gontero P; Bosco O; Peluso R; Fortunati N; Frairia R; Catalano MG
    PLoS One; 2016; 11(12):e0168553. PubMed ID: 28002459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting gastrin-releasing peptide receptors on small cell lung cancer cells with a bispecific molecule that activates polyclonal T lymphocytes.
    Zhou J; Chen J; Zhong R; Mokotoff M; Shultz LD; Ball ED
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2224-31. PubMed ID: 16609038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel and TRAIL synergize to kill paclitaxel-resistant small cell lung cancer cells through a caspase-independent mechanism mediated through AIF.
    Hunter TB; Manimala NJ; Luddy KA; Catlin T; Antonia SJ
    Anticancer Res; 2011 Oct; 31(10):3193-204. PubMed ID: 21965726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New application of an old drug: Antitumor activity and mechanisms of doxycycline in small cell lung cancer.
    Wang SQ; Zhao BX; Liu Y; Wang YT; Liang QY; Cai Y; Zhang YQ; Yang JH; Song ZH; Li GF
    Int J Oncol; 2016 Apr; 48(4):1353-60. PubMed ID: 26846275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-
    Wu M; Wang Y; Wang Y; Zhang M; Luo Y; Tang J; Wang Z; Wang D; Hao L; Wang Z
    Int J Nanomedicine; 2017; 12():5313-5330. PubMed ID: 28794625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herceptin-decorated paclitaxel-loaded poly(lactide-
    Zhong S; Ling Z; Zhou Z; He J; Ran H; Wang Z; Zhang Q; Song W; Zhang Y; Luo J
    Pharm Dev Technol; 2020 Apr; 25(4):454-463. PubMed ID: 31873051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
    Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
    Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of VEGFR2-targeted CD-TK-loaded cationic nanobubbles in the treatment of bladder cancer.
    Hu C; Jiang D; Wu M; Wang J; Zhang R
    J Cancer Res Clin Oncol; 2020 Jun; 146(6):1415-1426. PubMed ID: 32180070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wentilactone A induces cell apoptosis by targeting AKR1C1 gene via the IGF-1R/IRS1/PI3K/AKT/Nrf2/FLIP/Caspase-3 signaling pathway in small cell lung cancer.
    Jiang W; Meng L; Xu G; Lv C; Wang H; Tian H; Chen R; Jiao B; Wang B; Huang C
    Oncol Lett; 2018 Nov; 16(5):6445-6457. PubMed ID: 30405782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer.
    Wu M; Zhao H; Guo L; Wang Y; Song J; Zhao X; Li C; Hao L; Wang D; Tang J
    Drug Deliv; 2018 Nov; 25(1):226-240. PubMed ID: 29313393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anlotinib Inhibits Cell Proliferation, Migration and Invasion via Suppression of c-Met Pathway and Activation of ERK1/2 Pathway in H446 Cells.
    Tang X; Zheng Y; Jiao D; Chen J; Liu X; Xiong S; Chen Q
    Anticancer Agents Med Chem; 2021; 21(6):747-755. PubMed ID: 32682383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.